DFTX
🟢 Definium Therapeutics is trading 4.22% up today after positive Phase 3 Panorama results
Definium Therapeutics is trading 4.22% up at $38.38 after investors continued responding to positive Phase 3 Panorama results for DT120 in generalized anxiety...